Show Summary Details
Page of

Addiction 

Addiction
Chapter:
Addiction
Author(s):

R. Douglas Bruce

DOI:
10.1093/med/9780195399349.003.0046
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 June 2019

Substance use disorders can increase the risk of HIV infection directly, through the sharing of needles among injection drug users, and indirectly, through facilitation of high-risk sexual contacts. It is therefore not surprising that many HIV-infected patients have one or more substance use disorders. Substance use can impede adherence to HIV treatment regimens, resulting in significant morbidity and mortality, including the development of HIV resistance. Evidenced-based treatments for substance use disorders, consisting of psychosocial support, mental health counseling, and pharmacotherapy for addiction, are necessary to improve health outcomes in this population. This chapter focuses on pharmacotherapy for substance use disorders.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.